[EN] TRPV4 ANTAGONISTS<br/>[FR] ANTAGONISTES DE TRPV4
申请人:GLAXOSMITHKLINE LLC
公开号:WO2011119701A1
公开(公告)日:2011-09-29
The present invention relates to quinoline analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.
本发明涉及喹啉类似物、含有它们的药物组合物以及它们作为TRPV4拮抗剂的用途。
Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds
申请人:MITSUI TOATSU CHEMICALS, Inc.
公开号:EP0726254B1
公开(公告)日:1998-05-06
TRPV4 ANTAGONISTS
申请人:GlaxoSmithKline LLC
公开号:EP2549872A1
公开(公告)日:2013-01-30
US5627193A
申请人:——
公开号:US5627193A
公开(公告)日:1997-05-06
Quinoline-4-carbonylguanidine derivatives, process for producing the
申请人:Mitsui Toatsu Chemicals, Inc.
公开号:US05627193A1
公开(公告)日:1997-05-06
The present invention relates to quinoline-4-carbonylguanidine derivative represented by formula (1) ##STR1## and pharmaceutically acceptable salt thereof, a process for producing the same, and a Na.sup.+ /H.sup.+ exchanger inhibitor containing the compound as an active ingredient. The compounds of the present invention are useful as an agent for treating or preventing various diseases by hyperfunction of the Na.sup.+ /H.sup.+ exchanger and as a diagnostic agent for these diseases.